Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cohbar Inc. (CWBR : NSDQ)
 
 • Company Description   
Cohbar, Inc. operates is a biotechnology company. It engaged in the research and development of mitochondria-based therapeutics for the treatment of diseases associated with aging. Cohbar, Inc. is based in Menlo Park, California.

Number of Employees: 10

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.20 Daily Weekly Monthly
20 Day Moving Average: 432,371 shares
Shares Outstanding: 86.98 (millions)
Market Capitalization: $17.77 (millions)
Beta: 2.50
52 Week High: $2.27
52 Week Low: $0.18
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -21.42% -11.49%
12 Week -24.19% -16.65%
Year To Date -41.61% -28.66%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1455 Adams Drive Suite 2050
-
Menlo Park,CA 94025
USA
ph: 650-446-7888
fax: -
jordyn.tarazi@cohbar.com http://www.cohbar.com
 
 • General Corporate Information   
Officers
Joseph Sarret - Chief Executive Officer
David Greenwood - Chairman
Jeffrey F. Biunno - Chief Financial Officer; Treasurer and Secretary
Carol Nast - Director
Joanne Yun - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 19249J109
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/09/22
Share - Related Items
Shares Outstanding: 86.98
Most Recent Split Date: (:1)
Beta: 2.50
Market Capitalization: $17.77 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.04 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.13 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.77
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 42.86%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -78.78
12/31/21 - -91.80
09/30/21 - -115.35
ROA
03/31/22 - -70.82
12/31/21 - -79.98
09/30/21 - -96.61
Current Ratio
03/31/22 - 19.53
12/31/21 - 15.95
09/30/21 - 6.77
Quick Ratio
03/31/22 - -
12/31/21 - 15.95
09/30/21 - 6.77
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 0.26
12/31/21 - 0.30
09/30/21 - 0.21
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©